Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study

Authors

Evan S. Dellon (ORCID: https://orcid.org/0000-0003-1167-1101)
Camilla A. Richmond
Ikuo Hirano (ORCID: https://orcid.org/0000-0001-7688-9377)
Mena Boules (ORCID: https://orcid.org/0000-0002-5962-9271)
Brian Terreri (ORCID: https://orcid.org/0000-0002-8736-2009)
Vincent A. Mukkada (ORCID: https://orcid.org/0000-0003-4225-5506)
Gary W. Falk (ORCID: https://orcid.org/0000-0002-7143-1436)
Margaret H. Collins (ORCID: https://orcid.org/0000-0002-0756-5974)
David A. Katzka (ORCID: https://orcid.org/0000-0003-2307-2317)
Bridgett Goodwin
Manoj Kumar Thakur

Institutions

Northwestern University (US)
University of North Carolina at Chapel Hill (US)
Cincinnati Children's Hospital Medical Center (US)
Columbia University Irving Medical Center (US)
Takeda (United States) (US)
Takeda (Japan) (JP)
University of Cincinnati (US)
University of Pennsylvania (US)

Publication Details

Journal: Clinical Gastroenterology and Hepatology
Published: 2025-02-13
DOI: https://doi.org/10.1016/j.cgh.2024.12.024
Citations: 6
Primary Topic: Eosinophilic Esophagitis
Type: article
Field-Weighted Citation Impact: 12.04

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study

Evan S. Dellon, Camilla A. Richmond, Ikuo Hirano, Mena Boules et al.

Feb 13, 2025

6 citations

Clinical Gastroenterology and Hepatology

Eosinophilic Esophagitis

12.04

article

Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study

Evan S. Dellon, Camilla A. Richmond, Ikuo Hirano, Mena Boules, Brian Terreri, Vincent A. Mukkada, Gary W. Falk, Margaret H. Collins, David A. Katzka, Bridgett Goodwin, Manoj Kumar Thakur

February 13, 2025article en

6 citations

Abstract

No abstract available for this paper.

Clinical Gastroenterology and HepatologyVol. 23(12)

Northwestern University (US), University of North Carolina at Chapel Hill (US), Cincinnati Children's Hospital Medical Center (US), Columbia University Irving Medical Center (US), Takeda (United States) (US), Takeda (Japan) (JP), University of Cincinnati (US), University of Pennsylvania (US)

Good health and well-being

Openalex Percentile: Top 1%

Eosinophilic Esophagitis

12.04

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study — Evan S. Dellon, Camilla A. Richmond, et al. · Clinical Gastroenterology and Hepatology (2025) | TGRS Research Map | TGRS